Latest Financial Results

Q1 2023
Quarter Ended Mar 31, 2023
Latest Annual Filing
For Fiscal Year Ending Dec 31, 2022
Report Links
Email Alerts
Receive updates straight into your inbox
Company Overview
HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack.
View Management Team View Board of DirectorsInvestor Contact Information
Company
HeartBeam, Inc.
2118 Walsh Avenue
Suite 210
Santa Clara, CA 95050
T: 408-899-4443
Investor Relations
MZ North America
Chris Tyson
Executive Vice President
T: 949-491-8235
BEAT@mzgroup.us
Transfer Agent
VStock Transfer
18 Lafayette Place
Woodmere, NY 11598